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The chemical nature of peptides provides a nearly infinite diversity in structure, accessible by highly robust and parallel synthesis protocols (Rademann and Jung, 2000) . Therefore peptides provide a highly valuable repertoire of molecular interactors, both in basic and applied biomedical research (Cooper and Waters, 2005) . In the past years, numerous peptides have been approved as drugs (Bray, 2003; Hruby and Balse, 2000; Leader et al., 2008) .
Nevertheless, the intracellular applicability of peptides is still limited. One major drawback of peptides is their short cytoplasmatic half-life. Major investments have been made to increase the stability of peptides. Terminal capping by acetylation (N-terminus) and amidation (Cterminus) is the most straightforward modification for increasing the resistance of a peptide to serum proteases (Brinckerhoff et al., 1999) . The incorporation of non-native amino acids such as D-amino acids (Chorev et al., 1979; Tugyi et al., 2005) beta-amino acids (Frackenpohl et al., 2001; Griffith, 1986) or backbone modifications such as N-methylation (Gordon et al., 2001 ) have been presented as possible solutions. However, these approaches do not only render the synthesis more time-consuming and expensive, they also require a careful revalidation of the structure-activity relationship of the molecule (Ruijtenbeek et al., 2001 ).
An alternative approach that is well established in order to extend the plasma half-life of small molecule drugs in the bloodstream and to prevent liver accumulation is the conjugation of the drugs to high-molecular weight polymers (Duncan, 2003; Vicent and Duncan, 2006) . In this context the HPMA copolymer has been widely used (Kopecek and Bazilova, 1973; Malugin et al., 2004; Satchi-Fainaro et al., 2004) . For peptides, coupling to dendrimers has yielded a protection from proteolytic breakdown (Bracci et al., 2003) .
In a previous study, we have shown that coupling of peptides containing an N-terminal cysteine residue to thioester-preactivated HPMA polymers is a convenient and robust method for production of polymer-coupled peptides via native chemical ligation (Dawson et al., 1994;  This article has not been copyedited and formatted. The final version may differ from this version. 
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5 Ruttekolk et al., 2008; Tam et al., 2001) . Conjugates containing an apoptosis-enhancing peptide, loaded into cells by electroporation had a greatly increased biological activity in comparison to the free peptide. Correspondingly, bifunctional conjugates containing the apoptosis-enhancing peptide and nonaarginine (R9) as a cell-penetrating peptide (CPP) Wender et al., 2000) showed a higher biological activity than the free bioactive peptide extended by the CPP.
Differences in import efficiency, retention time inside the cell and stabilization from proteolytic breakdown were considered as the basis for these observations. However, the structure of the bioactive peptide compromised a determination of the molecular mechanism.
The peptide required free and unmodified seven N-terminal amino acids for bioactivity and could therefore only be linked to the polymer via a cysteine residue coupled to a C-terminal lysine side chain. Therefore, a fluorescence-based assessment of proteolytic cleavage of the polymer-coupled peptide was not possible. Ideally, a peptide used for the analysis of proteolytic stability should be coupled to the polymer via its N-terminus and carry a fluorescent reporter group at its C-terminus.
Here, we therefore selected a Bid-derived BH3 peptide as a model peptide (Cory et al., 2003; Kuwana et al., 2002; Willis and Adams, 2005) . This peptide has a length of 22 amino acids and does not require a free amino terminus for biological activity. Coupling to the polymer occurred straightforward via an N-terminal cysteine residue. A fluorescein label was attached to a C-terminal lysine residue. Therefore, in contrast to our previous choice, this peptide was ideally suited to detect proteolytic cleavage off the polymer and release of C-terminal low molecular weight fluorescein-labeled fragments. The BH3 peptide can directly induce apoptosis by interacting with the multidomain proapoptotic BCL-2 family protein BAX. BAX forms homo-oligomers at the mitochondrial membrane and triggers the release of cytochrome c and other proapoptotic factors (Kuwana et al., 2002; Walensky et al., 2006) . The induction This article has not been copyedited and formatted. The final version may differ from this version. 
6 of mitochondrial apoptosis by the Bid BH3-peptide, conjugated to the cell-penetrating peptide d-octaarginine was shown before (Goldsmith et al., 2006) .
In order to eliminate the complex CPP-mediated import kinetics, involving endosomal release , first the free peptides and the conjugates were introduced into the cell via electroporation and the bioactivity of both was investigated. The free peptide was N-terminally capped by labeling with fluorescein and C-terminally blocked by amidation.
Again the polymer-coupled peptide exhibited a greatly increased activity in Jurkat T cell leukemia cells and in Hela cells.
Import efficiency and intracellular distribution were analyzed by confocal laser scanning microscopy and flow cytometry. The intracellular retention was addressed by time-lapse microscopy in combination with quantitative image analysis. Subsequently, the proteolytic stability was compared by incubation of conjugate and peptide with crude cell lysate. The latter experiment was performed by fluorescence correlation spectroscopy (FCS) (Rigler et al., 1993) . This fluorescence-based analytical technique provides information about the average number and size of fluorescently labeled molecules that diffuse through a subfemtoliter confocal detection volume. The method is separation-free. Therefore, less than one picomole referring to a few nanograms of the labeled construct were required per measurement.
For the HPMA-peptide conjugate the import efficiency was reduced and the intracellular retention of fluorescence did not widely differ between HPMA-conjugate and free peptide.
However, the stability against cytosolic proteases was tremendously increased. Finally, we demonstrate that a bifunctional HPMA-peptide conjugate, containing R9 as a cell-penetrating peptide next to the functional BH3 peptide induced apoptosis in a specific and concentrationdependent manner. Together, the results demonstrate a generalization of our HPMA-based approach and provide a mechanistic basis for the advantages of this approach. This article has not been copyedited and formatted. The final version may differ from this version. Peptide synthesis. Peptides were synthesized by automated solid-phase peptide synthesis using Fmoc/tBu chemistry. Fluorescein-labeled peptides with a C-terminal fluorophore were synthesized on preloaded carboxyfluorescein-labeled lysyl-Rink amide resin ((Fluo(Trt))-LysRink) (Fischer et al., 2003) , unlabeled peptides on Rink amide resin. N-terminal labeling proceeded as described previously (Fischer et al., 2003 Determination of stoichiometry by FCS. The determination of stoichiometry proceeded as described previously (Ruttekolk et al., 2008) Subsequently, 900 μL RPMI medium was added carefully and the cells were incubated for 5 min at RT, followed by washing of the cell suspension in medium by centrifugation. Hela cells were electroporated in a total volume of 500 μl at a density of 10 7 cells/ml using a 10 ms pulse of 300 V (Fischer Electroporator, Heidelberg) . Cells were then resuspended in fresh medium and incubated for 6 h at 37°C.
Bioactivity of conjugates.
For the testing of the activity of electroporated conjugates by annexin V staining, the electroporated cells were washed, transferred to a 24-well tissue culture plate with flat bottom (Sarstedt, Nümbrecht, Germany) and incubated for 20 h in RPMI medium. Subsequently, the cells were washed in cold PBS and incubated in 100 μL annexin-binding buffer (10 mM HEPES, 140 mM NaCl and 2.5 mM CaCl 2 , pH 7.4) containing 5 μL annexin-V Alexa Fluor 647 for 15 min on ice. 400 μL annexin-binding buffer was added and the samples were analyzed by flow cytometry with a FACSCalibur System (BD Biosciences, San Jose, USA).
This article has not been copyedited and formatted. The final version may differ from this version. For microscopy, using an LSM510 confocal microscope (Carl Zeiss, Jena, Germany), Alexa647-labeled annexin V was excited with a 633 nm helium-neon laser and fluorescence detected using an LP 650 long pass filter.
Caspase activity was measured in HeLa and Jurkat cells electroporated with peptides or polymers as described above. Furthermore, cell-penetrating constructs were tested on Jurkat cells. 10 6 Jurkat E6.1 cells were incubated with increasing concentrations of free BH3-R9 / mBH3-R9 peptide and R9-HPMA-BH3 / R9-HPMA-mBH3 conjugates for 6 hours at 37ºC.
Cells were washed once with ice-cold PBS, lysed in lysis buffer (20 mM Tris/HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, pH 7.7) supplemented with protease inhibitor cocktail tablets (Roche Diagnostics, Mannheim, Germany) for half an hour on ice. The protein content in lysates was determined using a commercially available Bradford protein assay kit (Bio Rad Laboratories, München, Germany). Equivalents of 20 µg protein for each sample was diluted in caspase activity buffer (20 mM HEPES,10 mM dithiothreitol, 10% glycerol, 100 mM NaCl, pH 7.5). Fluorogenic caspase-3 substrate (Ac-DEVD-AMC, Calbiochem, Bad Soden, Germany) was added to the samples to a final concentration of 2 µM. Fluorescence was detected in a Synergy 2 single-channel microplate reader (BioTek Instruments, Inc., Winooski, USA) was analyzed immediately after substrate addition and after 3 h incubation at 37ºC.
Analysis of peptide release. 5 x 10 5 electroporated Jurkat E6.1 cells were incubated in 200 μL phenol red-free RPMI medium for 10 min at 37 °C until they had settled on the bottom of a 8-well chambered coverglass (Nunc, Rochester, USA). Subsequently, the cells were analyzed by confocal laser scanning microscopy using a Leica SP5 confocal microscope removed by centrifugation (20,000 g for 20 min at 4°C). The supernatant was split into two aliquots of 500 μL, each, into which either 2 μM HPMA-BH3 conjugate or the free BH3 peptide were added. The concentration of the cell suspension was adjusted so that the degradation of the peptide and conjugate could be followed over several hours. The samples were incubated at 37°C. At the indicated times samples of 5 μL were taken, mixed with 95 μL protease inhibitor cocktail (Complete, Roche Diagnostics, Mannheim, Germany) and frozen.
Finally, the frozen samples were thawed, 1000 μL Tris buffer (100 mM Tris-HCl, pH 8. 
Results
Synthesis and analytical characterization of HPMA-peptide conjugates. Following our previously published procedure (Ruttekolk et al., 2008) , the BH3 peptide, containing an uncapped N-terminal cysteine residue was coupled to an active ester-activated HPMA polymer by native chemical ligation. A conjugate containing only fluorescein-labeled cysteine-lysyl moeities and a conjugate carrying a mutated BH3 peptide, in which three residues were replaced for alanines, were employed as negative controls. The positions of the first and second alanine exchanges correspond to conserved amino acids. These mutations had been implemented into negative controls before (Goldsmith et al., 2006) . We had decided to Bioactivity of electroporated conjugates. Cellular import by electroporation of functional conjugates lacking a cell-penetrating moiety was chosen to elucidate whether coupling to the polymer affected the activity per peptide. In electroporation cells are briefly exposed to a strong electric field that transiently introduces pores into the plasma membrane (Gehl, 2003) .
Electroporation is a powerful method to introduce molecules directly into the cytoplasm of cells. For our analyses of intracellular activity, electroporation therefore circumvented the This article has not been copyedited and formatted. The final version may differ from this version. 
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14 complications of endosomal uptake, breakdown and release associated with CPP-mediated cellular import Fotin-Mleczek et al., 2005) . After washing by centrifugation, Jurkat E6.1 or HeLa cells were incubated for 6 h to allow the induction of apoptosis. Apoptosis induction was assessed by measuring caspase-3 activity. As a further assay for induction of apoptosis, Jurkat E6.1 cells were incubated with annexin-V Alexa fluor 647. Annexin-V binds to the phospholipid phosphatidylserine on the cell surface, which is externalized to the outer leaflet of the plasma membrane during apoptosis. An increase in caspase-3 activity was observed for the HPMA-BH3 conjugates in Jurkat E6.1 and HeLa cells (Fig. 1A-B) . As the indicated concentrations represent peptide concentrations, this result demonstrates that the specific activity of the peptides was increased considerably due to the conjugation of the peptides to polymers. Annexin-V confirmed that only the HPMA-BH3
conjugate initiated apoptosis in a concentration-dependent manner, but not the mutant HPMA-mBH3 or the cysteine-containing HPMA construct ( Fig. 1C-E) .
We then aimed to resolve the molecular basis of the different activities. Next to a mere difference in electroporation efficiency of the polymer and the free peptide, differences in intracellular residence time or stabilization from proteolytic breakdown were considered.
Quantification of electroporation efficiency. In a first step, we compared the electroporation efficiency of the conjugates and the free peptides. To this end, 30 μM of the free BH3 peptide and the HPMA-BH3 conjugate were electroporated into Jurkat E6.1 cells.
The intracellular fluorescence was quantified by flow cytometry and observed by confocal laser scanning microscopy 1 h after electroporation. All electroporated cells were positive for fluorescence. The fluorescence of cells loaded with the free BH3 peptide was approximately 4-fold higher than that of cells loaded with the HPMA-BH3 conjugate (Fig. 2) . Considering that (i) the polymer carried on overage two BH3 peptides per polymer and (ii) both the free This article has not been copyedited and formatted. The final version may differ from this version. Determination of intracellular retention. The induction of apoptosis was determined 6 and 20 h after electroporation. We therefore reasoned that the higher biological activity could be explained by a longer residence time of the higher molecular weight conjugates. For a comparison of residence times, Jurkat E6.1 cells were electroporated with 30 μM solutions of the peptides and conjugates. The cells were washed and observed by confocal laser scanning microscopy over time in a chase experiment (Fig. 3) . Subsequently, the images were analyzed by digital image analysis and the average brightness of the cells was calculated (Fig. 4) . The fluorescence residence time of the unbound BH3 peptide had a half-life of 5.8 ± 1.8 h, the one for the free mBH3 peptide 5.0 ± 1.1 h, the HPMA-BH3 conjugate 10.6 ± 7.4 h and the HPMA-mBH3 conjugate 4.4 ± 1.7 h. In contrast, the free fluorescein molecules had an intracellular half-life of less than 0.5 h. For the HPMA-conjugates larger errors were found repeatedly due to the lower intensity of cellular fluorescence that also precluded an observation over longer times. The intracellular distribution did not change significantly over time (Fig. 5) . In all cases, fluorescence remained homogeneously distributed inside the cytoplasm demonstrating that no sequestration into intracellular structures occurred. These results indicate that rapid cellular exit of the free peptide cannot be the reason for the increased activity of HPMA-conjugated peptides.
Peptide stability in cell lysate. Having excluded differences in loading and rapid cellular exit of the free peptide as the source for the increased biological activity, we therefore addressed peptide 57 μs and for the digested samples 25 μs. By fixing these values, the fractions of intact and degraded polymer/peptide were derived from two component fits to the autocorrelation functions. After an incubation time of 2 h the free BH3 peptide was nearly fully degraded, as only 6 % of the peptide was intact, whereas 68 % of the HPMA-BH3 was still intact (Fig. 7) . As shown for cell lysate above also in living cells the HPMA conjugated peptides are more stable.
Biological activity of a bifunctional cell-penetrating conjugate. Finally, we addressed whether cofunctionalization of the HPMA polymer with a cell-penetrating moiety would yield a bioactive conjugate to induce apoptosis by CPP-mediated cell entry. The modular assembly of CPP and BH3 peptide as independent building blocks on the polymer backbone constitutes a clear advantage over the synthesis of one long cell-penetrating BH3-R9 peptide.
The conjugate effectively induced apoptosis in Jurkat cells in a concentration-dependent manner as measured by caspase-3 activation, while the conjugate functionalized with the mutated peptide did not (Fig. 8) . The R9-HPMA-BH3 conjugate was more effective in inducing apoptosis than the free R9-BH3 peptide, consistent with the results for the electroporated peptides. The mutant free R9-conjugated mBH3 peptide also induced some apoptosis, albeit less reproducibly and to a lesser extent than the R9-HPMA-BH3 conjugate.
This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
Our previous analyses had shown that coupling of peptides to an HPMA polymer by native chemical ligation yielded bioactive conjugates by a modular design (Ruttekolk et al., 2008) .
These initial analyses had already indicated that the polymer-coupled peptides had a higher activity per peptide moiety. Differences in cellular loading efficiency, in retention inside the cell as well as in peptide stability were considered as the molecular basis for this observation.
However, the bioactive peptide, derived from the proapoptotic protein Smac (Fulda et al., 2002) , that we had selected, was not accessible to an elucidation of these questions. For this peptide a free amino terminus was required for activity. Therefore, coupling to the polymer occurred via a cysteine residue coupled to a lysine side chain at the C-terminus of the peptide.
Here, we selected an apoptosis-inducing peptide derived from the proapoptotic Bid protein that could be coupled to the polymer via the N-terminus in a straightforward manner.
Coupling efficiencies for this longer peptide were in the same range as those reported before, confirming the general usefulness and robustness of this synthesis procedure.
Using this peptide we demonstrate an increase in the activity per peptide moiety that is very likely due to a protection from proteolytic degradation. Given the faster degradation of the free peptide one could also expect a faster release of degradation products from the cells.
However, cellular retention times of fluorescence were not markedly different for the free peptides and for conjugates. We explain this observation by the generation of fluoresceincontaining fragments that were still efficiently retained within the cells. We have indications from other experiments that negatively charged peptides are retained more strongly inside a cell than positively charged or neutral ones. The two N-terminal amino acid residues glutamic acid and aspartic acid are negatively charged.
For the HPMA-conjugated peptide the activity was increased considerably per peptide moiety. The HPMA-mBH3 conjugate and the fluorescein-conjugated polymer did not show This article has not been copyedited and formatted. The final version may differ from this version. 
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19 any activity. This finding confirmed that induction of caspase-3 activity and phosphatidylserine exposure were not due to electroporation or to a toxic effect by the polymer itself.
In contrast to the HPMA-BH3 conjugate, the free BH3 peptide did not show any activity, in spite of the higher electroporation efficiency. For this free peptide, in vitro assays had shown that concentrations of 10 μM and more were required to induce formation of Bax oligomers (Kuwana et al., 2005) . Only for a membrane-targeted analog or a peptide with a stabilized α-helix were activities at lower concentrations observed. We therefore conclude that due to the rapid proteolytic breakdown of the free peptide concentrations required for activity were not reached.
A conjugate of this peptide to the CPP d-octaarginine had shown apoptosis inducing activity in a number of cancer cells (Goldsmith et al., 2006) at concentrations of 20 μM and higher.
These concentrations were higher than the ones used for the cell-penetrating conjugate in our experiments.
While our studies focused on the intracellular pharmacokinetics of the free peptides and HPMA-peptide conjugates, it is nevertheless interesting to note that the HPMA-BH3
conjugate was active in spite of its lower electroporation efficiency. It is tempting to speculate that next to the proteolytic stabilization, the multivalency of this conjugate may contribute to this observation. This multivalency should enable the simultaneous interaction with at least two Bax molecules. In nature and also in the generation of synthetic binders, multivalency is a highly powerful principle for increasing the interaction of low-affinity binders (Lee and Lee, 2000; Rao et al., 1998) .
Finally, the HPMA-based strategy also proved its potential as a modular synthesis approach for the combination of different functionalities. Synthesis of a single 31 amino acid peptide containing the BH3 domain and the nonaarginine CPP is a major challenge and we repeatedly This article has not been copyedited and formatted. The final version may differ from this version. For the cell-penetrating R9-HPMA-BH3 conjugate the same higher activity was observed in comparison to the free peptide as was observed for the molecules that were loaded by electroporation.
In summary, our results provide a powerful methodological approach to address the pharmacokinetics of peptides and polymer conjugates in intracellular applications.
Fluorescence correlation spectroscopy was employed as an analytical method to determine proteolytic degradation in microliter volumes of crude cell lysates in a separation-free
manner. The analyses demonstrate that conjugation of peptides to the HPMA polymer confers significant protection from proteolytic degradation. Together with the robust, modular synthesis procedure, these results further underline the usefulness of the HPMA-based strategy to increase the functionality of peptides in intracellular applications in fundamental and applied biomedical research.
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30 conjugates and the free peptides, the normalized mean and mean error of two and four independent experiments is shown.
